MGO One Seven’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Sell
5,506
-89
-2% -$49.9K 0.05% 392
2026
Q1
$3.14M Sell
5,595
-463
-8% -$297K 0.06% 339
2025
Q4
$4.1M Sell
6,058
-36
-0.6% -$24.5K 0.08% 279
2025
Q3
$3.89M Buy
6,094
+151
+3% +$91.7K 0.09% 247
2025
Q2
$3.19M Buy
+5,943
New +$2.84M 0.1% 222
2019
Q1
Sell
-12
Closed -$2K 974
2018
Q4
$2K Buy
+12
New +$2.46K ﹤0.01% 1568
2018
Q1
$14K Hold
72
0.01% 982
2017
Q4
$11K Buy
+72
New +$11.3K 0.01% 1066

Other funds holding IDXX

MGO One Seven's IDXX Position: Q2 2026 in Review

MGO One Seven reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, selling an estimated $49.9K and leaving 5,506 shares worth $2.9M. The position accounts for 0.05% of the portfolio, ranked #392.

MGO One Seven first reported a position in IDXX in Q4 2017 and has held it in 8 quarters since. The position peaked at $4.1M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • MGO One Seven held 5,506 shares of Idexx Laboratories worth $2.9M as of Q2 2026.
  • MGO One Seven sold 89 Idexx Laboratories shares in Q2 2026, an estimated $49.9K.
  • Idexx Laboratories made up 0.05% of MGO One Seven's portfolio in Q2 2026, its #392 holding.
  • MGO One Seven first reported a position in Idexx Laboratories in Q4 2017 and has held it in 8 quarters since.
  • MGO One Seven's Idexx Laboratories position peaked at $4.1M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.